ADMA Biologics (ADMA) Financials

$9.62

$0.04 (0.42%)

As on 04-Sep-2026 19:29EDT

Market cap

$2,146 Mln

Revenue (TTM)

$512 Mln

P/E Ratio

13.7

P/B Ratio

5.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	512.28	510.17	426.45	258.22	154.08	80.94
Cost of Revenue	180.81	217.41	206.90	169.27	118.82	79.77
Gross Profit	331.47	292.77	219.55	88.94	35.27	1.17
Operating Expenses	114.91	101.32	80.57	67.31	74.63	59.55
Operating Profit (EBIT)	216.50	191.44	138.98	21.63	-39.37	-58.37
Other Income	--	--	--	--	-7.26	-0.22
Profit before Tax	216.47	182.66	125.71	-28.24	-65.90	-71.65
Provision for Tax	47.52	35.73	-71.96	8.16	19.28	12.81
Profit after Tax (Net Income)	168.96	146.93	197.67	-28.24	-65.90	-71.65
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-65.90	-71.65

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	408.21	477.32	349.02	135.21	151.97	141.17
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	200.25	77.38	84.12	144.17	157.22	104.70
Current Liabilities	75.76	69.54	55.54	49.81	39.27	30.38
Total Liabilities	759.97	624.24	488.68	329.18	348.46	276.25

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	156.01	157.73	157.27	72.17	78.06	67.52
Current Assets	528.20	466.51	331.41	257.01	270.40	208.73
Total Assets	759.97	624.24	488.68	329.18	348.46	276.25
Total Debt*	203.84	79.89	82.12	141.42	154.44	102.92
Net Current Assets	452.45	396.97	275.87	207.21	231.13	178.35

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	50.40	118.67	8.80	-59.51	-112.37
Cash Flow from Investing Activities	--	-21.89	-8.58	-4.98	-13.91	-13.51
Cash from Financing Activities	--	-44.02	-58.30	-38.99	108.85	121.05
Net Cash Inflow / Outflow	--	--	--	--	35.43	-4.83

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	0.70	0.60	0.80	-0.12	-0.32	-0.40
Cash EPS ($)	--	0.64	0.84	-0.09	-0.29	-0.37
Adjusted Book Value ($)	--	1.96	1.42	0.60	0.75	0.78
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.21	0.48	0.04	-0.29	-0.62
Free Cash Flow per Share ($)	--	0.11	0.45	0.02	-0.36	-0.70

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	29.73	55.86	-9.69	-23.94	-33.32
ROE (%)	38.16	35.56	81.65	-19.67	-44.96	-62.46
ROA (%)	24.25	26.40	48.34	-8.33	-21.10	-29.61
EBIT Margin (%)	43.98	37.20	32.75	-1.24	-30.26	-72.39
Net Margin (%)	32.98	28.80	46.35	-10.94	-44.89	-88.75
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	8.04	0.20	0.65	0.68	0.90	0.92
EBIT Growth (%)	45.17	35.89	4,447.57	93.11	20.42	8.11
Net Profit Growth (%)	-19.13	-25.67	800.00	57.15	8.02	5.41
EPS Growth (%)	-17.05	-0.25	7.43	0.62	0.18	0.49
Book Value Growth (%)	10.61	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	13.69	30.27	21.33	-36.17	-11.94	-3.56
Price / Book Value	5.26	9.32	12.08	7.55	5.18	1.81
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	9.51	22.44	28.41	217.08	-21.64	-5.78
Close Price ($)	8.37	18.24	17.15	4.52	3.88	1.41
High Price ($)	20.46	25.67	23.64	4.65	3.92	3.11
Low Price ($)	7.21	13.50	4.37	2.95	1.26	1.01
Market Cap ($ Cr)	2,145.77	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.47	0.17	0.24	1.05	1.02	0.73
Short term debt to equity ratio	0.01	0.01	0.00	0.01	0.01	0.00
Current Ratio	6.97	6.71	5.97	5.16	6.89	6.87
Quick Ratio	3.81	3.74	2.90	1.69	2.73	2.77
Interest Coverage	25.53	26.69	10.02	-0.13	-2.42	-4.49

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	26.98	31.05	11.72	10.62	10.06	35.30
Asset Turnover	0.74	0.92	1.04	0.76	0.49	0.33
Receivable days	--	74.61	33.15	30.36	52.25	94.34
Inventory Days	--	316.43	302.88	362.70	442.68	472.21
Payable days	--	35.90	31.67	31.17	39.44	53.81
Cash Conversion Cycle	--	355.14	304.36	361.90	455.49	512.74

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.